GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Andon Health Co 002432.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

52.41

+0.40%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.37bn

FY2016FY2025

Net income

CN¥2.27bn

FY2016FY2025

Free cash flow

−CN¥431.1m

FY2016FY2025

Shareholders' equity

CN¥21.83bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.37bnCN¥2.59bnCN¥3.23bnCN¥2.40bnCN¥2.01bnCN¥706.3mCN¥563.9mCN¥597.9mCN¥420.1m
Research and developmentCN¥323.6mCN¥269.2mCN¥278.5mCN¥66.7mCN¥78.3mCN¥80.0mCN¥68.9mCN¥94.1mCN¥41.5m
Operating income−CN¥296.5mCN¥2.11bnCN¥1.61bnCN¥919.3mCN¥238.6mCN¥20.5m−CN¥91.9m−CN¥171.3mCN¥8.2m
Net incomeCN¥2.27bnCN¥1.67bnCN¥1.25bnCN¥908.6mCN¥242.3mCN¥66.4mCN¥12.7m−CN¥165.9mCN¥14.5m
Diluted earnings per share5.533.792.802.000.560.150.03-0.380.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥29.31bnCN¥26.34bnCN¥22.62bnCN¥3.93bnCN¥2.53bnCN¥1.94bnCN¥1.95bnCN¥2.10bnCN¥2.36bn
Cash and short-term investments—CN¥10.45bnCN¥11.27bnCN¥1.34bnCN¥1.20bnCN¥732.0mCN¥528.4mCN¥654.7mCN¥791.7m
Total liabilitiesCN¥7.28bnCN¥4.84bnCN¥2.79bnCN¥1.09bnCN¥704.8mCN¥341.7mCN¥381.9mCN¥729.1mCN¥814.6m
DebtCN¥1.45bnCN¥2.63bnCN¥1.51bnCN¥242.9mCN¥344.4mCN¥197.5mCN¥222.5mCN¥70.0mCN¥446.8m
Shareholders' equityCN¥21.83bnCN¥20.74bnCN¥19.23bnCN¥2.87bnCN¥1.88bnCN¥1.66bnCN¥1.58bnCN¥1.37bnCN¥1.54bn
Shares outstanding410m441m448m454m433m433m402m440m422m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CN¥166.8mCN¥986.8mCN¥1.77bnCN¥293.1mCN¥461.6m−CN¥43.7m−CN¥104.2m−CN¥91.9m−CN¥36.5m
Capital spending−CN¥264.3m−CN¥73.9m−CN¥212.7m−CN¥70.4m−CN¥53.8m−CN¥60.7m−CN¥179.7m−CN¥56.5m−CN¥69.6m
Free cash flow−CN¥431.1mCN¥912.8mCN¥1.56bnCN¥222.7mCN¥407.9m−CN¥104.4m−CN¥283.9m−CN¥148.4m−CN¥106.1m
Dividends paid−CN¥186.9m−CN¥190.7m−CN¥1.18bn−CN¥36.7m−CN¥6.7m−CN¥8.7m−CN¥6.3m−CN¥11.0m−CN¥4.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥229.8mCN¥301.5mCN¥296.3mCN¥304.0mCN¥258.3mCN¥507.0mCN¥500.1mCN¥741.1m
Operating income−CN¥96.7mCN¥1.6m−CN¥85.0m−CN¥61.6m−CN¥196.1mCN¥303.6mCN¥292.2mCN¥257.9m
Net incomeCN¥2.78bnCN¥293.5mCN¥677.7mCN¥668.9mCN¥653.9mCN¥266.3mCN¥300.1mCN¥766.9m
Diluted earnings per share6.770.721.651.631.590.650.681.74
Cash from operations———CN¥521.0mCN¥8.0mCN¥7.0mCN¥291.0mCN¥531.0m
Capital spending—−CN¥94.0m−CN¥34.0m−CN¥160.0m−CN¥24.0m−CN¥44.0m−CN¥38.0m−CN¥6.0m
Free cash flow———CN¥361.0m−CN¥16.0m−CN¥37.0mCN¥253.0mCN¥525.0m
Total assetsCN¥33.75bnCN¥29.91bnCN¥29.31bnCN¥28.98bnCN¥28.66bnCN¥26.67bnCN¥26.34bnCN¥24.46bn
Cash and short-term investments———CN¥13.87bnCN¥11.43bnCN¥10.22bnCN¥10.45bnCN¥10.53bn
DebtCN¥1.76bnCN¥2.11bnCN¥1.45bnCN¥2.94bnCN¥3.79bnCN¥2.38bnCN¥2.61bnCN¥2.86bn
Shareholders' equityCN¥23.14bnCN¥21.62bnCN¥21.83bnCN¥22.19bnCN¥21.77bnCN¥21.42bnCN¥20.74bnCN¥19.27bn

Financial ratios

Data as of 28 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-21.7%81.4%49.9%69.6%38.4%11.9%
Net margin166.0%64.4%38.7%60.9%37.9%12.1%
Return on equity10.4%8.0%6.5%82.0%31.6%12.9%
Return on assets7.7%6.3%5.5%73.8%23.1%9.6%
Free cash flow yield0.4%4.1%7.5%68.2%1.4%2.0%
Revenue growth-47.3%-19.8%-87.7%997.8%19.4%184.4%
Earnings growth35.8%33.3%-92.2%1664.2%275.0%264.7%
Current ratio2.65x5.50x7.90x16.52x2.75x3.22x
Debt to equity0.07x0.13x0.08x0.01x0.07x0.16x
Equity ratio74.5%78.7%85.0%90.0%73.1%74.6%
Interest coverage-2.61x30.39x105.94x2719.80x53.57x24.84x
R&D as a share of sales23.7%10.4%8.6%0.9%2.8%3.9%
Buybacks as a share of market value6.9%1.5%2.1%-0.8%-4.8%-0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-62.7%-7.4%13.1%
Operating income——6.8%
Net income-47.9%56.4%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin45.8%64.9%60.4%55.4%
Net margin99.4%63.3%59.0%54.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings7.210.813.51.524.716.533.1162.7-24.7452.3
Price to sales12.06.95.20.99.42.03.13.76.815.6

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 3 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2015FY2012
Paid in the year1.650.200.302.500.700.060.020.067
  • 3-for-2 split · 31 May 2013
  • 2-for-1 split · 27 May 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.